Showing 1 - 13 results of 13 for search 'Mónica Argueso', query time: 0.04s Refine Results
  1. 1
    Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality.

    Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality. by Leonardo Lorente, María M Martín, Pedro Abreu-González, Luis Ramos, Mónica Argueso, Jordi Solé-Violán, Marta Riaño-Ruiz, Alejandro Jiménez

    Published 2015-01-01
    Get full text
    Article
  2. 2
    The Serum Melatonin Levels and Mortality of Patients with Spontaneous Intracerebral Hemorrhage

    The Serum Melatonin Levels and Mortality of Patients with Spontaneous Intracerebral Hemorrhage by Leonardo Lorente, María M. Martín, Pedro Abreu-González, Luis Ramos, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2019-10-01
    Get full text
    Article
  3. 3
    High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality

    High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality by Leonardo Lorente, María M. Martín, Antonia Pérez-Cejas, Luis Ramos, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2018-03-01
    Get full text
    Article
  4. 4
    Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients

    Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients by Leonardo Lorente, María M. Martín, Pedro Abreu-González, Luis Ramos, Juan J. Cáceres, Mónica Argueso, Jordi Solé-Violán, Alejandro Jiménez, Victor García-Marín

    Published 2019-12-01
    Get full text
    Article
  5. 5
    Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage

    Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage by Leonardo Lorente, María M. Martín, Antonia Pérez-Cejas, Luis Ramos, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2018-04-01
    Get full text
    Article
  6. 6
    Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.

    Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study. by Leonardo Lorente, María M Martín, Agustín F González-Rivero, Mónica Argueso, Luis Ramos, Jordi Solé-Violán, Juan J Cáceres, Alejandro Jiménez, Juan M Borreguero-León

    Published 2015-01-01
    Get full text
    Article
  7. 7
    Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels

    Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels by Leonardo Lorente, María M. Martín, Pedro Abreu-González, Rafael Sabatel, Luis Ramos, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2019-10-01
    Get full text
    Article
  8. 8
    Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury

    Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury by Leonardo Lorente, María M. Martín, Pedro Abreu-González, Antonia Pérez-Cejas, Luis Ramos, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2017-07-01
    Get full text
    Article
  9. 9
    High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients

    High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients by Leonardo Lorente, María M. Martín, Agustín F. González-Rivero, Antonia Pérez-Cejas, Mónica Argueso, Luis Ramos, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2019-10-01
    Get full text
    Article
  10. 10
    Early Mortality of Brain Infarction Patients and Red Blood Cell Distribution Width

    Early Mortality of Brain Infarction Patients and Red Blood Cell Distribution Width by Leonardo Lorente, María M. Martín, Pedro Abreu-González, Antonia Pérez-Cejas, Agustín F. González-Rivero, Luis Ramos-Gómez, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2020-03-01
    Get full text
    Article
  11. 11
    Mortality prediction of ischemic stroke patients without thrombectomy by blood total antioxidant capacity

    Mortality prediction of ischemic stroke patients without thrombectomy by blood total antioxidant capacity by Leonardo Lorente, María M. Martín, Agustín F. González-Rivero, Antonia Pérez-Cejas, Pedro Abreu-González, Rafael Sabatel, Luis Ramos-Gómez, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, Victor García-Marín

    Published 2020-09-01
    Get full text
    Article
  12. 12
    High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients

    High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients by Leonardo Lorente, María M. Martín, Luis Ramos, Mónica Argueso, Juan J. Cáceres, Jordi Solé-Violán, Alejandro Jiménez, Juan M. Borreguero-León, Agustín F. González-Rivero, Josune Orbe, José A. Rodríguez, José A. Páramo

    Published 2019-07-01
    Get full text
    Article
  13. 13
    Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.

    Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury. by Leonardo Lorente, María M Martín, Patricia López, Luis Ramos, José Blanquer, Juan J Cáceres, Jordi Solé-Violán, Jorge Solera, Judith Cabrera, Mónica Argueso, Raquel Ortiz, María L Mora, Santiago Lubillo, Alejandro Jiménez, Juan M Borreguero-León, Agustín González, Josune Orbe, José A Rodríguez, José A Páramo

    Published 2014-01-01
    Get full text
    Article

Search Tools: